• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tempus to Report Second Quarter 2024 Financial Results on August 6

By: Tempus AI, Inc. via Business Wire
July 17, 2024 at 09:30 AM EDT

Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the second quarter on Tuesday, August 6, 2024. The company will hold the second quarter 2024 earnings conference call at 4:30 p.m. ET. The company’s quarterly earnings will be released the same day.

The call will feature Tempus Founder and CEO, Eric Lefkofsky, and Chief Financial Officer, Jim Rogers. The live audio webcast will be accessible through the events page of Tempus’ Investor Relations website. Alternatively, the call can be accessed via the following:

Conference ID: 6326328

Domestic Dial-in Number: (800) 715-9871

International Dial-in Number: (646) 307-1963

Live Webcast: https://edge.media-server.com/mmc/p/75k462fh

About Tempus

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240717119736/en/

Contacts

Tempus Communications

Erin Carron

Erin.carron@tempus.com

Tempus Investor Relations

Elizabeth Krutoholow

Elizabeth.krutoholow@tempus.com

H/Advisors Abernathy

Dan Scorpio

Dan.scorpio@h-advisors.global

More News

View More
Auto Tariffs Are Coming Down: 3 Stocks to Benefit Soon
Today 10:28 EDT
Via MarketBeat
Topics Government World Trade
Tickers AAP F STLA
Tencent Music Stock Outshines Spotify as China’s Music Giant
Today 9:30 EDT
Via MarketBeat
Topics Economy
Tickers NTES SPOT TCEHY TME
DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy?
August 30, 2025
Via MarketBeat
Tickers DKS
Engines to AI: Cummins’ Surprising Growth Driver
August 30, 2025
Via MarketBeat
Topics Artificial Intelligence Earnings Energy
Tickers CMI
Smaller Industrials Names Seeing Surging Growth: Here's Why
August 30, 2025
Via MarketBeat
Topics Earnings
Tickers AZZ CAT DY PRIM XLI
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap